IGM Biosciences Inc.

NASDAQ: IGMS · Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 13, 2025, 3:59 PM
1.28
0.79%
After-hours: Aug 13, 2025, 06:49 PM EDT

IGM Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
143.62M 499K 412K 516K 1.25M 497K 651K 509K 448K 522K 372K 331K 366K n/a n/a n/a n/a n/a
Cost of Revenue
441K n/a 2.35M n/a 2.28M 2.18M 2.18M 2.26M 3.52M n/a 3.22M 2.62M 2.53M 2.23M 2.18M 1.95M 2.25M 1.34M
Gross Profit
143.18M 499K -1.94M 516K -1.02M -1.68M -1.53M -1.75M -3.07M 522K -2.85M -2.29M -2.17M -2.23M -2.18M -1.95M -2.25M -1.34M
Operating Income
130.29M -54.78M -38.98M -64.39M -51.36M -53.86M -65.12M -66.76M -68.21M -63.37M -56.26M -60.51M -59.22M -51.96M -50.68M -44.2M -38.74M -31.71M
Interest Income
1.32M 1.88M 2.33M 2.96M 3.46M 4.04M 4.67M 5.01M 3.89M 4.17M 3.75M 2.48M 760K 54K n/a 35K n/a n/a
Pretax Income
97.58M -52.89M -36.65M -61.43M -47.9M -49.82M -60.45M -61.75M -64.31M -59.22M -52.58M -58.04M -58.59M -51.89M -50.64M -44.16M -38.71M -31.64M
Net Income
97.58M -52.89M -36.65M -61.43M -47.9M -49.82M -60.7M -61.99M -64.42M -59.31M -48.2M -55.56M -57.97M -51.83M -50.64M -44.16M -38.71M -31.64M
Selling & General & Admin
8.49M 11.05M 10.46M 18.76M 10.65M 10.54M 11.58M 12.51M 12.98M 13M 11.62M 12.66M 12.37M 13.08M 11.51M 10M 8.65M 8.13M
Research & Development
4.4M 22.34M 28.93M 46.14M 41.96M 43.81M 54.19M 54.76M 55.67M 50.89M 45.02M 48.18M 47.22M 38.88M 39.17M 34.2M 30.09M 23.57M
Other Expenses
n/a 21.89M n/a n/a n/a n/a n/a n/a n/a n/a -58K n/a 629K 62K 38K 35K 24K 62K
Operating Expenses
12.89M 55.27M 39.39M 64.9M 52.61M 54.35M 65.77M 67.27M 68.66M 63.9M 56.64M 60.84M 59.59M 51.96M 50.68M 44.2M 38.74M 31.71M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.33M 55.27M 39.39M 64.9M 52.61M 54.35M 65.77M 67.27M 68.66M 63.9M 56.64M 60.84M 59.59M 51.96M 50.68M 44.2M 38.74M 31.71M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 242K 240K 109K 87K -4.38M -2.48M -629K -62K n/a n/a n/a n/a
Shares Outstanding (Basic)
61.46M 61.16M 60.51M 60.66M 60.43M 60.11M 59.83M 59.58M 45.12M 44.47M 44.24M 44.03M 43.92M 33.84M 33.78M 33.44M 33.37M 33.33M
Shares Outstanding (Diluted)
61.75M 61.16M 60.51M 60.66M 60.43M 60.11M 59.83M 59.58M 45.12M 44.47M 44.24M 44.03M 43.92M 33.84M 33.78M 33.44M 33.37M 33.33M
EPS (Basic)
1.59 -0.86 -0.61 -1.01 -0.79 -0.83 -1.01 -1.04 -1.43 -1.33 -1.09 -1.26 -1.32 -1.53 -1.5 -1.32 -1.16 -0.95
EPS (Diluted)
1.58 -0.86 -0.61 -1.01 -0.79 -0.83 -1.01 -1.04 -1.43 -1.33 -1.09 -1.26 -1.32 -1.53 -1.5 -1.32 -1.16 -0.95
EBITDA
98.02M -30.61M -36.63M -62.08M -49.08M -51.68M -62.94M -64.5M -66.03M -61.71M -54.37M -59M -57.78M -50.73M -49.38M -43.1M -37.33M -31.03M
EBIT
97.58M -32.89M -38.98M -64.39M -51.36M -53.86M -65.12M -66.76M -68.21M -63.37M -56.26M -60.51M -59.22M -51.96M -50.68M -44.2M -38.74M -31.71M
Depreciation & Amortization
441K 2.27M 2.35M 2.31M 2.28M 2.18M 2.18M 2.26M 2.17M 1.66M 3.22M 2.62M 2.53M 2.23M 2.18M 1.95M 2.25M 1.34M